Redefining Medicine’s Future
Fourth Generation Medicine
Over 50 Patented Innovations for a Better Medical Future
Introducing Fourth Generation Medicine (4GM)
Fourth Generation Medicine (4GM) is redefining healthcare with over 50 patented diagnostic and therapeutic strategies, addressing humanity’s most pressing diseases, from Long COVID to neuropsychiatric syndromes, metabolic diseases, infections diseases, autoimmunity, neuro-degeneration and other conditions. Our intellectual property, developed through decades of relentless research, represents a groundbreaking leap in medical innovation, offering solutions with profound societal implications. Filed with Fish & Richardson, the nation’s premier intellectual property firm, our patents ensure unparalleled robustness and protection, positioning 4GM as a leader in the next era of medicine.
Our vision is transformative: a massive market opportunity and a chance to participate in a revolutionary update in national and global healthcare. By targeting diseases with no current effective solutions 4GM’s IP delivers hope to millions. Our diagnostics and therapies are innovative, scalable, and poised to reshape how the world approaches health, from root cause identification to treatment. Details of our proprietary strategies are confidential, available only through in-person meetings and formal NDAs, safeguarding the integrity of our pioneering work.
4GM’s business model focuses on monetizing our IP through strategic partnerships, leveraging our patents to drive value and impact. This approach includes plans for a state-of-the-art drug manufacturing plant and cutting-edge diagnostic equipment, further amplifying our contribution to healthcare. Backed by a world-class board— 4GM ensures its innovations reach global markets. Our commitment to science and a healthier world drives us to transform lives.
With 50+ patents, 4GM is not just a company—it’s a movement.
We invite partners, investors, and visionaries to join our journey, redefining medicine’s future.
Our Subsidiary Ecosystem: Driving a Massive Medical Revolution
Fourth Generation Medicine (4GM) operates through four specialized subsidiaries, each advancing our mission to redefine medicine’s future. Backed by over 50+ Provisional Patents and Fish & Richardson’s legal expertise, our subsidiaries—4th Generation Research, 4th Generation Pharmaceuticals, 4th Generation Diagnostics, and 4th Generation Nutraceuticals—target diseases with no current effective solutions. 4th Generation Research collaborates with U.S.-based CRO labs to validate therapies. 4th Generation Pharmaceuticals develops novel drugs and plans a manufacturing plant for its proprietary medicines. 4th Generation Diagnostics pioneers a new testing paradigm with specialized equipment testing novel labs to aid diagnosis and guide therapy. 4th Generation Nutraceuticals creates synergistic therapies to complement pharmaceuticals in the management of diseases. Together, these subsidiaries form a powerhouse of intellectual property and promise towards a better future of more effective and safer healthcare , for the United States and for the World.
Contact Us
With 50+ patents, 4GM is not just a company—it’s a movement. We invite partners, investors, and visionaries to join our journey as we redefine the future of healthcare.
Email: jr@4gm.net Email: info@4gm.net
